NCT02449122View on ClinicalTrials.gov

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Lung Cancer
Interventions
PROCEDURE

interventional therapy

Lung cancer patients received drug interventional therapy using the digital subtraction angiography（DSA.）

Trial Locations (1)

510000

Central laboratory in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02449122 - Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma | Biotech Hunter | Biotech Hunter